How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?

Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients. This paradoxical response corresponds to an acceleration in tumor growth and a dramatic decrease of patient survival. The reported incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Denis, Morgane, Duruisseaux, Michael, Brevet, Marie, Dumontet, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098964/
https://www.ncbi.nlm.nih.gov/pubmed/32265935
http://dx.doi.org/10.3389/fimmu.2020.00492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098964/
https://www.ncbi.nlm.nih.gov/pubmed/32265935
http://dx.doi.org/10.3389/fimmu.2020.00492

Ejemplares similares